Pharmaceutical Glass Packaging Market

The pharmaceutical glass packaging market is projected to reach USD 6.36 billion by 2030 from USD 3.10 billion in 2025, at a CAGR of 15.5% from 2025 to 2030. This growth is attributed to the rising demand for glass packaging due to its inert properties, making it ideal for preserving the efficacy and stability of high-potency drugs such as biologics. The increasing use of glass in drug delivery systems, especially in vials and ampoules for injectables, further supports the market's expansion. Innovations in glass treatment processes are enhancing its application scope, ensuring better drug protection and patient safety.

In August 2022, Schott AG partnered with major pharmaceutical companies to enhance glass vial production capabilities. This partnership strategy aims to strengthen Schott AG's manufacturing capacity in pharmaceutical glass packaging, improving production efficiency and product quality to better serve the growing demand for sterile packaging solutions in the pharmaceutical industry.

To know about the assumptions considered for the study download the pdf brochure

In January 2024, Schott AG launched a new line of eco-friendly glass ampoules, aligning with sustainability goals. This product development allows Schott AG to offer environmentally conscious packaging solutions to the pharmaceutical market, addressing the industry's increasing focus on sustainable practices while maintaining the high quality and safety standards required for drug packaging.

The key players in this market include Schott AG (Germany), Gerresheimer AG (Germany), BD (US), and other notable contributors expanding and enriching the market with their innovative equipment for workflow efficiency and healthcare quality.

Schott AG, a leading company based in Germany, has captured a significant share of the pharmaceutical glass packaging market due to its innovative and effective packaging solutions. As a prominent player in specialty glass and glass-ceramics manufacturing, Schott AG offers pharmaceutical glass packaging products that not only deliver superior chemical and thermal properties but also provide effective protection for high-potency drugs and biologics. Over the years, Schott AG has continually improved and expanded its range of pharmaceutical glass packaging solutions, including Type I neutral or borosilicate glass vials and ampoules, to ensure drug integrity and high levels of customer satisfaction.

Gerresheimer AG, based in Germany, secured one of the largest shares in the pharmaceutical glass packaging market. Gerresheimer AG specializes in pharmaceutical and healthcare packaging, and over time, it has become an important player in glass packaging solutions for the pharmaceutical industry. The company is known for delivering excellent products with innovative features, such as advanced coating technologies that minimize glass breakage and enhance product shelf life, improving the quality of life for patients requiring injectable medications. In recent years, Gerresheimer AG has expanded its capabilities through strategic partnerships and collaborations with pharmaceutical manufacturers. In March 2023, Gerresheimer AG merged with a local glass tooling firm to expand its manufacturing capacity, aiming to introduce enhanced pharmaceutical glass packaging solutions and help the industry gain better knowledge about safe and effective drug delivery systems. In September 2023, Gerresheimer AG achieved FDA clearance for its latest glass vial coating technology.

MARKET RANKING

The key players in the pharmaceutical glass packaging market have gained recognition for their comprehensive product offerings and continuous technological innovations. Some of the major players in the pharmaceutical glass packaging market include Schott AG (Germany), Gerresheimer AG (Germany), BD (US), Nipro Corporation (Japan), Stevanato Group (Italy), SGD Pharma (France), Ardagh Group (Luxembourg), Bormioli Pharma (Italy), Owens-Illinois (US), Piramal Glass (India), and Corning Incorporated (US). Schott AG and Gerresheimer AG have gained recognition for offering sophisticated glass packaging solutions, including easy-to-use models for various pharmaceutical applications. BD and Schott AG maintain market leadership through their integrated pharmaceutical glass packaging products, enabling safe, precise drug delivery and prompt clinical decision-making in both routine and specialized healthcare settings. Other notable contributors are expanding and enriching the market with their innovative equipment for workflow efficiency and healthcare quality. The key players have contributed significantly, increasing the reach of pharmaceutical glass packaging solutions in the global market.

Related Reports:

Pharmaceutical Glass Packaging Market by Type (Ampoules, Vials, Bottles, Syringes), Material (Type I, Type II, Type III), Drug Type, Manufacturing Process, Application (Injectables, Vaccines, Biologics), End user, and Region - Global Forecast To 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]